These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 5927179

  • 1. [Experiences with antitubercular agents of the second line].
    Zierski M.
    Wien Med Wochenschr; 1966 Oct 01; 116(40):824-7. PubMed ID: 5927179
    [No Abstract] [Full Text] [Related]

  • 2. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK, Singh SK.
    Indian J Chest Dis; 1973 Jan 01; 15(1):16-20. PubMed ID: 4695462
    [No Abstract] [Full Text] [Related]

  • 3. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP, Agarwala MC, Singh SK.
    Indian J Chest Dis; 1967 Oct 01; 9(4):196-206. PubMed ID: 4323543
    [No Abstract] [Full Text] [Related]

  • 4. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES, Komarova AA.
    Sov Med; 1967 Jun 01; 30(6):107-10. PubMed ID: 5611339
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases.
    Fischer DA, Lester W, Dye WE, Moulding TS.
    Am Rev Respir Dis; 1968 Mar 01; 97(3):392-8. PubMed ID: 5638494
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H, Opl G.
    Prax Pneumol; 1968 Nov 01; 22(11):692-8. PubMed ID: 5714048
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M, Zacara A, Woźniak S.
    Gruzlica; 1968 Sep 01; 36(9):809-18. PubMed ID: 4882450
    [No Abstract] [Full Text] [Related]

  • 16. [Tuberculostatic drugs of the second series. (Review of literature)].
    El'nik VI.
    Klin Med (Mosk); 1966 Dec 01; 44(12):19-24. PubMed ID: 4302920
    [No Abstract] [Full Text] [Related]

  • 17. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct 01; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.